Issue 7/2021
Content (10 Articles)
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Daryl Hodge, David J. Back, Sara Gibbons, Saye H. Khoo, Catia Marzolini
Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses
Ibrahim El-Haffaf, Jean-Alexandre Caissy, Amélie Marsot
Clinical Impact of the Adaptation of Initial Tacrolimus Dosing to the CYP3A5 Genotype After Kidney Transplantation: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Hui Yang, Yiqi Sun, Xiaojia Yu, Xiaopeng Hu, Wei Wang, Xiaodong Zhang, Lihong Liu
Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN)
Shuying Yang, Laurie A. Lee, Neal Sule, Andrew Fowler, Guy Peachey
Glomerular Filtration Rate in Asphyxiated Neonates Under Therapeutic Whole-Body Hypothermia, Quantified by Mannitol Clearance
Neel Deferm, Kim V. Annink, Ruben Faelens, Michael Schroth, Christian A. Maiwald, Loubna el Bakkali, Frank van Bel, Manon J. N. L. Benders, Mirjam M. van Weissenbruch, Anja Hagen, Anne Smits, Pieter Annaert, Axel R. Franz, Karel Allegaert, Axel R. Franz, Mario Rüdiger, Christian F. Poets, Manon Benders, Frank van Bel, Karel Allegaert, Gunnar Naulaers, Dirk Bassler, Katrin Klebermass-Schrehof, Maximo Vento, Hercilia Guimaraes, Tom Stiris, Isabella Mauro, Marjo Metsäranta, Sampsa Vanhatalo, Jan Mazela, Tuuli Metsvaht, Yannique Jacobs
Intranasal Fentanyl for Intervention-Associated Breakthrough Pain After Cardiac Surgery
Antti Valtola, Maisa Laakso, Henriikka Hakomäki, Brian J. Anderson, Hannu Kokki, Veli-Pekka Ranta, Valtteri Rinne, Merja Kokki
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors
Chandrasekar Durairaj, Jayeta Chakrabarti, Cristiano Ferrario, Holger W. Hirte, Sunil Babu, Sarina A. Piha-Paul, Anna Plotka, Justin Hoffman, Haihong Shi, Diane D. Wang
Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII
Fredrik Jonsson, Christophe Schmitt, Claire Petry, Francois Mercier, Nicolas Frey, Sylvie Retout
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
Stijn W. van Beek, Rob ter Heine, Jan-Willem C. Alffenaar, Cecile Magis-Escurra, Rob E. Aarnoutse, Elin M. Svensson, M. J. Boeree, E. Burhan, R. Dawson, A. H. Diacon, S. Gillespie, C. M. Mtabho, N. E. Ntingiya, N. Heinrich, W. Hoefsloot, M. Hoelscher, G. Kibiki, K. Reither, I. Sanne, H. H. Semvua, A. Tostmann
Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
Stijn W. van Beek, Rob ter Heine, Jan-Willem C. Alffenaar, Cecile Magis-Escurra, Rob E. Aarnoutse, Elin M. Svensson, M. J. Boeree, E. Burhan, R. Dawson, A. H. Diacon, S. Gillespie, C. M. Mtabho, N. E. Ntingiya, N. Heinrich, W. Hoefsloot, M. Hoelscher, G. Kibiki, K. Reither, I. Sanne, H. H. Semvua, A. Tostmann